CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Bacteriophage Therapy for Treatment of Clostridioides difficile: Clinical Effectiveness and Guidelines

Last updated: November 26, 2019
Project Number: RA1077-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Reference List
Result type: Report

Question

  1. What is the clinical effectiveness of bacteriophage therapy for the treatment of Clostridioides difficile?
  2. What are the evidence-based guidelines regarding the use of bacteriophage therapy for the treatment of Clostridioides difficile?

Key Message

No literature was identified regarding the clinical effectiveness of bacteriophage therapy for the treatment of Clostridioides difficile. In addition, no evidence-based guidelines were identified regarding the use of bacteriophage therapy for the treatment of Clostridioides difficile.